BioCentury
ARTICLE | Financial News

Aquinox sets IPO terms

March 1, 2014 1:10 AM UTC

Aquinox Pharmaceuticals Inc. (Vancouver, B.C.) amended its IPO and said it now plans to sell 3.7 million shares at $10-12. At the $11 midpoint, the company would raise $40.7 million and be valued at $105 million. Aquinox is seeking to list on NASDAQ and filed to raise up to $57.5 million in the offering last month. Jefferies; Cowen; and Canaccord are underwriters. ...